GRAUER & WEIL | TATVA CHINTAN PHARMA | GRAUER & WEIL/ TATVA CHINTAN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 30.4 | 77.0 | 39.5% | View Chart |
P/BV | x | 6.2 | 5.6 | 110.2% | View Chart |
Dividend Yield | % | 0.9 | 0.2 | 533.2% |
GRAUER & WEIL TATVA CHINTAN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GRAUER & WEIL Mar-23 |
TATVA CHINTAN PHARMA Mar-23 |
GRAUER & WEIL/ TATVA CHINTAN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 110 | 2,649 | 4.2% | |
Low | Rs | 54 | 1,606 | 3.4% | |
Sales per share (Unadj.) | Rs | 43.2 | 191.1 | 22.6% | |
Earnings per share (Unadj.) | Rs | 5.0 | 20.5 | 24.3% | |
Cash flow per share (Unadj.) | Rs | 5.9 | 24.8 | 23.6% | |
Dividends per share (Unadj.) | Rs | 0.80 | 2.00 | 40.0% | |
Avg Dividend yield | % | 1.0 | 0.1 | 1,036.6% | |
Book value per share (Unadj.) | Rs | 30.0 | 232.2 | 12.9% | |
Shares outstanding (eoy) | m | 226.71 | 22.17 | 1,022.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.9 | 11.1 | 17.1% | |
Avg P/E ratio | x | 16.5 | 103.7 | 15.9% | |
P/CF ratio (eoy) | x | 14.0 | 85.7 | 16.4% | |
Price / Book Value ratio | x | 2.7 | 9.2 | 29.9% | |
Dividend payout | % | 16.1 | 9.7 | 164.8% | |
Avg Mkt Cap | Rs m | 18,613 | 47,157 | 39.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 940 | 386 | 243.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 9,804 | 4,236 | 231.4% | |
Other income | Rs m | 220 | 57 | 382.6% | |
Total revenues | Rs m | 10,024 | 4,294 | 233.5% | |
Gross profit | Rs m | 1,523 | 572 | 266.3% | |
Depreciation | Rs m | 198 | 96 | 207.3% | |
Interest | Rs m | 25 | 86 | 29.4% | |
Profit before tax | Rs m | 1,520 | 448 | 339.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 390 | -7 | -5,509.7% | |
Profit after tax | Rs m | 1,130 | 455 | 248.3% | |
Gross profit margin | % | 15.5 | 13.5 | 115.1% | |
Effective tax rate | % | 25.7 | -1.6 | -1,623.6% | |
Net profit margin | % | 11.5 | 10.7 | 107.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 6,381 | 3,136 | 203.5% | |
Current liabilities | Rs m | 2,223 | 2,361 | 94.2% | |
Net working cap to sales | % | 42.4 | 18.3 | 232.0% | |
Current ratio | x | 2.9 | 1.3 | 216.1% | |
Inventory Days | Days | 31 | 3 | 1,045.4% | |
Debtors Days | Days | 684 | 73 | 940.4% | |
Net fixed assets | Rs m | 3,161 | 4,304 | 73.5% | |
Share capital | Rs m | 227 | 222 | 102.3% | |
"Free" reserves | Rs m | 6,565 | 4,926 | 133.3% | |
Net worth | Rs m | 6,792 | 5,148 | 131.9% | |
Long term debt | Rs m | 1 | 42 | 1.3% | |
Total assets | Rs m | 9,543 | 7,439 | 128.3% | |
Interest coverage | x | 61.0 | 6.2 | 983.4% | |
Debt to equity ratio | x | 0 | 0 | 0.9% | |
Sales to assets ratio | x | 1.0 | 0.6 | 180.4% | |
Return on assets | % | 12.1 | 7.3 | 166.5% | |
Return on equity | % | 16.6 | 8.8 | 188.2% | |
Return on capital | % | 22.7 | 10.3 | 221.1% | |
Exports to sales | % | 0 | 76.2 | 0.0% | |
Imports to sales | % | 9.4 | 56.9 | 16.5% | |
Exports (fob) | Rs m | NA | 3,229 | 0.0% | |
Imports (cif) | Rs m | 921 | 2,409 | 38.2% | |
Fx inflow | Rs m | 634 | 3,229 | 19.6% | |
Fx outflow | Rs m | 955 | 2,409 | 39.6% | |
Net fx | Rs m | -321 | 820 | -39.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,135 | 278 | 408.5% | |
From Investments | Rs m | -1,111 | -1,011 | 109.8% | |
From Financial Activity | Rs m | -235 | 378 | -62.3% | |
Net Cashflow | Rs m | -211 | -357 | 59.2% |
Indian Promoters | % | 69.1 | 72.0 | 95.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.0 | 16.5 | 5.9% | |
FIIs | % | 1.0 | 3.7 | 26.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 31.0 | 28.0 | 110.6% | |
Shareholders | 49,450 | 73,730 | 67.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare GRAUER & WEIL With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES GHCL
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | GRAUER & WEIL | TATVA CHINTAN PHARMA |
---|---|---|
1-Day | -0.05% | 0.02% |
1-Month | 4.05% | 9.97% |
1-Year | 63.94% | -23.68% |
3-Year CAGR | 64.12% | -18.73% |
5-Year CAGR | 30.38% | -11.70% |
* Compound Annual Growth Rate
Here are more details on the GRAUER & WEIL share price and the TATVA CHINTAN PHARMA share price.
Moving on to shareholding structures...
The promoters of GRAUER & WEIL hold a 69.1% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRAUER & WEIL and the shareholding pattern of TATVA CHINTAN PHARMA.
Finally, a word on dividends...
In the most recent financial year, GRAUER & WEIL paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 16.1%.
TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.
You may visit here to review the dividend history of GRAUER & WEIL, and the dividend history of TATVA CHINTAN PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.